Interactive Sessions On Hot Biopharmaceutical Industry Topics Highlight DIA 45th Annual Meeting June 21-25 In San Diego

Main Category: Pharma Industry / Biotech Industry
Also Included In: Conferences
Article Date: 17 Apr 2009 - 6:00 PDT

email to a friend   printer friendly   opinions  

The Drug Information Association (DIA) 45th Annual Meeting is the biopharmaceutical industry's largest and longest running global, multidisciplinary conference featuring more than 350 sessions and 34 preconference tutorials focused on issues affecting drug discovery and development including hot topic sessions on:

- Accelerated Development Time
- Adaptive Trial Design
- Biomarkers
- Biotechnology and Nonclinical Laboratory Safety Assessment
- Clinical Safety and Pharmacovigilance
- Critical Path Initiative
- Doing More for Less
- Future Directions of Project Management in the Life Sciences
- Global Clinical Trials
- Lean Six Sigma
- Oncology
- Patient Recruitment and Retention
- Patient Safety
- Pediatrics
- Pharmacogenomics and Personalized Medicines
- Pharmacovigilance and Risk Management
- Phase 1 Early Development
- Project Management
- Transparency
- USFDA Sentinel Initiative

Global drug development is also a key focus of the 45th Annual Meeting. This year's event will include sessions on issues affecting key regions of the world, including:

- Asia Pacific
- Australia
- Emerging Markets
- Europe
- India
- Latin America

"The global aspect brings together the top regulators, academics, patient groups, and industry professionals from different parts of the world," explains Program Committee Member Ling Su, PhD, and vice president, clinical research and development, Asia Pacific, Wyeth Pharmaceutical Co., Ltd., China. "The Annual Meeting provides a forum where they can share their experiences, perspectives and thinking on global drug development."

Three mega-tracks have been designed to enhance the quality of the presentations and to minimize overlap of similar session topics in different tracks. Mega-tracks include:

-- Information Technology
- Clinical Data Management
- eClinical
- Electronic Regulatory Submissions/Document Management/Information Technology
- Validation

-- Clinical Research
- Academic Health Centers/Investigative Sites
- Clinical Research and Development/Clinical Supplies
- Outsourcing
- Project Management/Finance

-- Advertising/Marketing/Medical Communications

The Meet the Regulators session (June 23 from 2:00 - 3:30 pm) provides the opportunity to hear from leaders of regulatory agencies in Europe and the United States. The Multi-track Plenary Session (June 22 from 3:30-5:00 pm), Improving Safety with Every Step: Pillars of the Pharmaceutical Landscape, brings together representatives from industry, regulatory agencies, academia and patient groups to share perspectives on how to enhance patient safety.

The two-part CDER Town Meeting is another highlight of the Annual Meeting. This unique session allows audience members to ask questions of a highly distinguished panel of senior leaders from the US FDA's Center for Drug Evaluation and Research (CDER).

"The CDER Town Meeting is exciting because there is no planned agenda, no pre-planned questions," says Program Chair Nancy D. Smith, PhD, former director, Office of Training and Communications, CDER, U.S. Food and Drug Administration. "It's purely what the audience wants to discuss.

About the Drug Information Association (DIA)

The Drug Information Association (DIA) serves more than 30,000 professionals from regulatory agencies, academia, and the biopharmaceutical industry worldwide. For more information, visit http://www.diahome.org or call 215-442-6100.

Source
Drug Information Association

• Additional
• References
• Citations